Current News

Contact | Print version | Send article | RSS feed

Orion Genomics Announces Notice Of Allowance For US Patent Covering Genome Wide Novel Biomarker Discovery Platform

20 Nov 2006 - Orion Genomics announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent application that covers Orion's MethylScope technology, a broad approach to discovering and quantifying the DNA methylation status on each and every gene in the human genome. The patent, authored by Orion co-founder, Rob Martienssen from Cold Spring Harbor Laboratory (CSHL), Eric Richards from Washington University, Zachary Lippmann from CSHL, and Vincent Colot from Centre National de la Recherche Scientifique, is expected to be issued in early 2007.
 
Orion's MethylScope technology, exclusively licensed from CSHL, is, according to the company, the only platform capable of detecting inappropriate DNA methylation for all human genes on a single array, providing an efficient and comprehensive biomarker discovery tool. By comparing methylation profiles, Orion discovers new biomarkers associated with specific diseases.